Devoted to a world without inherited cancer

LFS News

NCI: Making Strides Toward Precision Medicine for Individuals with Li-Fraumeni Syndrome

Read about the advancements in LFS research that our team at the Division of Cancer Epidemiology and Genetics, Clinical Genetics Branch, have accomplished in their March 2022 news update.

By |2024-07-11T15:16:55-04:00March 8th, 2022|LFS News|0 Comments

Li-Fraumeni Syndrome Association Lauds Advancements in Classifying Hereditary Cancer Risks

HOLLISTON, MA -- The Li-Fraumeni Syndrome Association (LFSA), dedicated to furthering research and worldwide awareness of the inherited cancer predisposition disorder, celebrates new findings published in the renowned JAMA Oncology journal with implications to better predict cancer risk. First presented at LFSA's 5th International Symposium last year, the concept of analyzing tumor patterns and

By |2024-07-11T15:16:55-04:00October 28th, 2021|LFS News, Press Release|0 Comments
Go to Top